"Acetanilides" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Compounds based on N-phenylacetamide, that are similar in structure to 2-PHENYLACETAMIDES. They are precursors of many other compounds. They were formerly used as ANALGESICS and ANTIPYRETICS, but often caused lethal METHEMOGLOBINEMIA.
| Descriptor ID |
D000083
|
| MeSH Number(s) |
D02.065.199.092 D02.092.146.113.092
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Acetanilides".
Below are MeSH descriptors whose meaning is more specific than "Acetanilides".
This graph shows the total number of publications written about "Acetanilides" by people in this website by year, and whether "Acetanilides" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2013 | 1 | 0 | 1 |
| 2014 | 1 | 0 | 1 |
| 2017 | 2 | 0 | 2 |
| 2018 | 3 | 0 | 3 |
To return to the timeline, click here.
Below are the most recent publications written about "Acetanilides" by people in Profiles.
-
Rationale and design of a multicentre, randomized, placebo-controlled trial of mirabegron, a Beta3-adrenergic receptor agonist on left ventricular mass and diastolic function in patients with structural heart disease Beta3-left ventricular hypertrophy (Beta3-LVH). ESC Heart Fail. 2018 10; 5(5):830-841.
-
Phase Ib Trial With Birabresib, a Small-Molecule Inhibitor of Bromodomain and Extraterminal Proteins, in Patients With Selected Advanced Solid Tumors. J Clin Oncol. 2018 10 20; 36(30):3007-3014.
-
Trends in the use of older overactive bladder agents and uptake of fesoterodine and mirabegron in Canada. Neurourol Urodyn. 2018 06; 37(5):1693-1700.
-
Systematic review and meta-analysis on the efficacy and tolerability of mirabegron for the treatment of storage lower urinary tract symptoms/overactive bladder: Comparison with placebo and tolterodine. Int J Urol. 2018 03; 25(3):196-205.
-
Potent, Selective, and Cell Active Protein Arginine Methyltransferase 5 (PRMT5) Inhibitor Developed by Structure-Based Virtual Screening and Hit Optimization. J Med Chem. 2017 07 27; 60(14):6289-6304.
-
Ranolazine refractory angina registry: 1-year results. Crit Pathw Cardiol. 2014 Sep; 13(3):96-8.
-
A novel anti-tumor inhibitor identified by virtual screen with PLK1 structure and zebrafish assay. PLoS One. 2013; 8(4):e53317.